Biphasic effects of chronic nicotine treatment on hypothalamic immunoreactive beta-endorphin in the mouse

Pharmacol Biochem Behav. 1985 Jul;23(1):141-3. doi: 10.1016/0091-3057(85)90141-8.

Abstract

Hypothalamic but not pituitary immunoreactive beta-endorphin (beta-E) was significantly reduced (37%) in mice 24 hr following 30 daily doses of nicotine (1200 micrograms/kg, SC). Hypothalamic beta-E returned towards normal levels within 7 days and was observed to rise 50% above normal 14 days after the cessation of nicotine treatment. None of the other neuropeptides measure, substance P, neurotensin, or [met5]-enkephalin was altered by nicotine treatment. The data suggest that the hypothalamic beta-E containing neurons were unable to adapt to nicotine's repeated effects on this system.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Endorphins / analysis
  • Endorphins / metabolism*
  • Enkephalin, Methionine / analysis
  • Humans
  • Hypothalamus / analysis*
  • Male
  • Mice
  • Mice, Inbred ICR
  • Neurotensin / analysis
  • Nicotine / adverse effects
  • Nicotine / pharmacology*
  • Pituitary Gland / analysis*
  • Substance P / analysis
  • Substance Withdrawal Syndrome
  • beta-Endorphin

Substances

  • Endorphins
  • Substance P
  • Neurotensin
  • Enkephalin, Methionine
  • beta-Endorphin
  • Nicotine